Deflazacort 6mg/5ml Suspension PCD Company in Maharashtra

Deflazacort 6mg/5ml Oral Suspension Franchise Supplier in Gujarat

Deflazacort 6mg/5ml Suspension Manufacturer in Karnataka

Best PCD Pharma for Deflazacort 6mg/5ml Oral Suspension in Rajasthan

Deflazacort 6mg/5ml Suspension Third Party Manufacturer in Punjab
Deflazacort 6mg/5ml Oral Suspension Exporter from India

Home/Products /deflazacort-6mg-suspension

About the Product

Description


Defziff Oral Suspension contains Deflazacort (6 mg/5 ml), a corticosteroid with anti-inflammatory and immunosuppressive properties. It works by reducing inflammation and modulating the immune response in various conditions.

It helps in the management of inflammatory, allergic, and autoimmune disorders, including asthma, rheumatoid arthritis, and other conditions requiring corticosteroid therapy.

May cause mild gastrointestinal upset, increased appetite, weight gain, mood changes, or sleep disturbances. Long-term use may lead to growth suppression in children, osteoporosis, or adrenal suppression.

Indicated for pediatric and adult patients requiring corticosteroid therapy for inflammatory or autoimmune conditions, under strict medical supervision.

Use only under medical supervision. Do not discontinue abruptly without consulting a doctor. Inform your physician of any infections, diabetes, hypertension, or liver/kidney issues.

Store below 25°C in a cool, dry place, protected from light. Keep out of reach of children. Shake well before use. Use as directed by the physician.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Deflazacort 6mg/5ml Suspension in the PCD pharma franchise market?

Deflazacort 6mg/5ml Suspension has strong demand in the pediatric anti-inflammatory and immunosuppressant segment, making it a high-potential product for medical distributors, wholesalers, and pharma franchise partners looking to expand in the PCD pharma pharma franchise market.

Why should medical distributors include Deflazacort Suspension in their product range?

Medical distributors and wholesalers can benefit from consistent demand in pediatric inflammatory conditions, allergic disorders, respiratory illnesses, and autoimmune conditions under medical supervision. It strengthens their pediatric and general medicine portfolio.

Does Cafoli Lifecare offer PCD pharma franchise opportunities for Deflazacort 6mg/5ml Suspension?

Yes, Cafoli Lifecare offers PCD pharma pharma franchise opportunities for Deflazacort 6mg/5ml Suspension with monopoly rights, quality packaging, competitive pricing, and reliable supply support for distributors and medical agencies.

What benefits do wholesalers get by partnering for this pediatric corticosteroid suspension?

Wholesalers and medical agencies benefit from steady prescription demand, repeat pediatric usage, and strong market acceptance in pediatric and respiratory care segments when partnering with Cafoli Lifecare.

How can I become a distributor or franchise partner for Deflazacort Suspension?

Medical distributors, stockists, wholesalers, and pharma professionals interested in this pediatric corticosteroid formulation can contact Cafoli Lifecare to discuss PCD pharma franchise opportunities, bulk procurement, pricing details, and distribution support services.